SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-032031
Filing Date
2016-05-16
Accepted
2016-05-16 16:17:17
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20160331_10q.htm 10-Q 680973
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12040
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12806
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7773
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7133
12 dffn20160331_10qimg001.jpg GRAPHIC 14883
  Complete submission text file 0001437749-16-032031.txt   4201886

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS dffn-20160331.xml EX-101.INS 694131
7 EXHIBIT 101.SCH dffn-20160331.xsd EX-101.SCH 54900
8 EXHIBIT 101.CAL dffn-20160331_cal.xml EX-101.CAL 28473
9 EXHIBIT 101.DEF dffn-20160331_def.xml EX-101.DEF 393028
10 EXHIBIT 101.LAB dffn-20160331_lab.xml EX-101.LAB 318722
11 EXHIBIT 101.PRE dffn-20160331_pre.xml EX-101.PRE 403334
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24477 | Film No.: 161654054
SIC: 2834 Pharmaceutical Preparations